Ministry licences three domestically-produced Molnupiravir drugs to treat COVID-19

21 February 2022
Vietnam Plus
Vietnam Plus, VNA
Pandemics
Covid-19 / Covid-19 treatment / điều trị Covid-19 / Molnupiravir

The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.

The three drugs are Molravir 400 produced by Boston Vietnam Pharma; Movinavir 200 mg manufactured by Mekophar Chemical Pharmaceutical; and Molnupiravir Stella 400 produced by Stellapharm J.V Co., Ltd.

Keep reading…

Ask Question
Report Problem
Share Idea
Send Feedback
Submit Resources

Do you have questions on the content published by Open Development Vietnam? We will gladly help you.

Have you found a technical problem or issue on the Open Development Vietnam website?

Tell us how we're doing.

Do you have resources that could help expand the Open Development Vietnam website? We will review any map data, laws, articles, and documents that we do not yet have and see if we can implement them into our site. Please make sure the resources are in the public domain or fall under a Creative Commons license.

View | Delete

File was deleted

ERROR!

Please add the code:

* The idea box couldn't be blank! * The email address is not valid! Something's gone wrong, Please Resubmit the form! Please add the code correctly first.

Ministry licences three domestically-produced Molnupiravir drugs to treat COVID-19

Contact us

Thank you for taking the time to get in contact!